Press Releases
Glooko Announces FDA 510(k) Clearance for EndoTool IV Cloud
Glooko announced that the U.S. Food and Drug Administration has granted 510(k) clearance for EndoTool IV Cloud for patient-specific insulin dosing in hospitals.
Read MoreGlooko and mylife Diabetes Care Expand Diabetes Data Management Partnership
Through an expanded partnership between Glooko and mylife Diabetes Care, Glooko will serve as the primary data management provider for mylife products.
Glooko Wins “Best Overall MedTech Software” in 2026 MedTech Breakthrough Awards
Glooko is the winner of the 2026 MedTech Breakthrough ‘Best Overall MedTech Software’ award for its diabetes and glycemic management software portfolio.
Mark Clements of Glooko recognized on Becker’s Healthcare’s 2026 ‘Great leaders in healthcare’ list
Glooko announced that Chief Medical and Strategy Officer Mark Clements, M.D., Ph.D., was named one of Becker's Healthcare's 2026 'Great leaders in healthcare.'
New EndoTool IV data presented at AACE show virtual elimination of severe hypoglycemia across 19 hospitals
Glooko revealed new data at AACE 2026 that demonstrated virtual elimination of severe hypoglycemia across 19 hospitals using EndoTool IV.
Glooko to Expand EMEA CGM Connectivity with Roche Accu-Chek® SmartGuide Integration
The Glooko diabetes management platform will integrate with the Roche Accu-Chek SmartGuide CGM solution across select European countries.
Glooko Appoints Former UCSF Health CEO and National Healthcare Leader Mark Laret to Board of Directors
Glooko announced the appointment of Mark Laret, one of the nation’s leading healthcare operators, innovators, and strategists, to its Board of Directors.